UNIVERSITY OF NEW MEXICO
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1889-01-01
- Employees
- 6.7K
- Market Cap
- -
- Website
- https://www.unm.edu/
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
- Conditions
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 22
- Registration Number
- NCT00276003
- Locations
- ๐บ๐ธ
Lovelace Sandia Health Systems Dept of Hematology, Albuquerque, New Mexico, United States
๐บ๐ธUniversity of New Mexico, Albuquerque, New Mexico, United States
Exercise Induced Bronchospasm in Children
- Conditions
- Interventions
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2008-05-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 13
- Registration Number
- NCT00273689
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
- Conditions
- First Posted Date
- 2005-11-10
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 10
- Registration Number
- NCT00251797
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study
- Conditions
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 15
- Registration Number
- NCT00250809
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Lung Cancer Case Registry and Tissue Resource
- Conditions
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2024-01-08
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 750
- Registration Number
- NCT00250848
- Locations
- ๐บ๐ธ
New Mexico Veterans Administration Health Care System, Albuquerque, New Mexico, United States
๐บ๐ธUniversity of New Mexico Cancer Center, Albuquerque, New Mexico, United States
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 12
- Registration Number
- NCT00250796
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
๐บ๐ธNew Mexico Cancer Care Associates, Santa Fe, New Mexico, United States
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
- Conditions
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 26
- Registration Number
- NCT00250783
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
- Conditions
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- University of New Mexico
- Registration Number
- NCT00250770
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Pharmacology Study of Aerosolized Liposomal
- Conditions
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- University of New Mexico
- Registration Number
- NCT00250120
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
- Conditions
- First Posted Date
- 2005-11-07
- Last Posted Date
- 2010-05-19
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 8
- Registration Number
- NCT00250068
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States